Board-certified toxicologist disseminating 15+ years of knowledge in nonclinical drug development.
Nov 12, 2026
•
1 min read
Just because it's a biologic doesn't mean it's easy.
Nov 5, 2026
2 min read
There's no single door into nonclinical.
Oct 29, 2026
This is what your recovery groups actually tell you.
Oct 22, 2026
The calls that make or break a program are the ones the guidance doesn't spell out.
Oct 15, 2026
It's actual on your critical path.
Oct 9, 2026
And it's free!
Oct 1, 2026
It's actually 1 of 4.
Sep 24, 2026
They run the work, but the data and decisions are yours.
Sep 17, 2026
More studies and data only means more headaches.
Sep 10, 2026
You still need animal studies.
Sep 3, 2026
No toxicity in a "toxicology" study won't tell you much.
Aug 27, 2026
Not every nonclinical program needs a rodent and a nonrodent.
Aug 20, 2026
Your DRF is.
Aug 13, 2026
GLP is actually only the beginning...
Aug 6, 2026
But it is where you start.
Jul 30, 2026
Wait...this doesn't add up...
Jul 23, 2026
It didn't have to be this way...
Jul 16, 2026
42 of 68 rounds this year went to drugs already in humans.
Jul 9, 2026
Here's how to create one and secure your road to the clinic.
Jul 2, 2026
There's always a data package, but that's not the same as IND-ready.
Jun 25, 2026
You think the clinic sets your trial's limits. Find out why it doesn't inside.
Jun 18, 2026
Learn the full nonclinical arc from start to IND
Jun 11, 2026
You see your data one way — how do others see it?
Jun 4, 2026
Spoiler alert: your GLP study isn't your pivotal study.
May 28, 2026
All the things you can do before you get to GLP.
